New clinical data from the MATCH Phase II study shows early improvement in liver function after treatment with non-engineered macrophages is associated ...
How AI, robotics, and precision medicine are transforming cancer care—bridging hope, technology, and humanity in the ongoing ...
Between Apple Pay, tap-to-pay cards, and one-click checkouts, our kids are growing up thinking money is just... magic?
TG Therapeutics, Inc. (NASDAQ: TGTX) Q3 2025 Earnings Call Transcript November 3, 2025 TG Therapeutics, Inc. beats earnings ...
Precigen, Inc. ( PGEN) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Good afternoon, ladies and gentlemen, and welcome to the Precigen Third Quarter 2025 Financial Results and Business Update ...
Life-saving stem cell transplants have been limited by the need to perfectly match the blood types of donors and recipients, ...
This expert-packed guide to the inevitable includes a workout, a grocery list, and answers to all our most awkward questions.
This festive season don’t just white-knuckle your way through the gatherings. Instead, mental health professionals offer therapeutic, evidence-based strategies ...
Cold air, dust and autumn walks can turn a harmless atchoo into a nagging puzzle for worried dog owners. A quick sneeze now ...
Q3 2025 Earnings Call November 3, 2025 4:30 PM ESTCompany ParticipantsRobert DeVitaDavid Hung - Founder, President, CEO ...
Papcemias FDA Approval -- Granted full FDA approval in August with the first and only available treatment for all adults with recurrent respiratory papillomatosis (RRP); label is broad with no ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback